Responses
Coronary artery disease
Original article
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.